GeNeuro SA

GeNeuro SA

Biotechnologieforschung

We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS and #LongCovid $GNRO

Info

GeNeuro is a biotechnology company developing innovative treatments against inflammatory and neurodegenerative disorders associated with Human Endogenous Retroviruses (HERVs). We are committed to fight the progression of disability in Multiple Sclerosis #FightMS and other neurodegenerative diseases #ALS #LongCOVID Our Community Guidelines: http://bit.ly/36y9YCE

Branche
Biotechnologieforschung
Größe
11–50 Beschäftigte
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Gegründet
2006
Spezialgebiete
Multiple Sclerosis, Progressive MS, ALS, SLA, HERV und Autoimmune diseases

Orte

Beschäftigte von GeNeuro SA

Updates

Ähnliche Seiten

Finanzierung